Long-term follow-up of smokers following lung and colorectal cancer diagnosis

2Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Continued smoking after a cancer diagnosis limits the effectiveness of treatment, increases the risk of cancer recurrence or secondary malignancies, and is associated with poorer quality of life and survival. A cancer diagnosis may provide a meaningful timepoint for quitting, but the prevalence and characteristics of continued smoking through survivorship are poorly understood. Methods: In the multi-regional Cancer Care Outcomes Research and Surveillance (CanCORS) cohort, we examined smoking rates and factors associated with continued smoking at long-term follow-up among lung and colorectal cancer patients. This paper builds upon previous CanCORS participant data addressing quit rates and associated characteristics at baseline and 5 months post-diagnosis. Results: At long-term follow-up (median 7.3 years post-diagnosis [IQR = 5.9–8.7]), 16.7% of lung cancer and 11.6% of colorectal cancer survivors continued to smoke combustible cigarettes. Factors independently associated with continued smoking at long-term follow-up included being male, younger, not married or partnered, having Medicare, Medicaid/other public or no insurance, more depression symptoms, smoking more cigarettes per day, and having a history of lung disease (p

Cite

CITATION STYLE

APA

Park, E. R., Skurla, S. E., Caballero, G. Y. J., Friedman, E. R., Ponzani, C., Wallace, R., … Keating, N. L. (2022). Long-term follow-up of smokers following lung and colorectal cancer diagnosis. Supportive Care in Cancer, 30(9), 7801–7809. https://doi.org/10.1007/s00520-022-07111-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free